Skip to main content
logo
MedCap AB (publ) (FRA:61MA)
Germany flag Germany · Delayed Price · Currency is EUR
48.50
+0.95 (2.00%)
At close: Jan 21, 2026

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Sweden Revenue
914.30M898.40M
Nordic (ex-Sweden) Revenue
567.70M448.60M
Europe (ex-Nordic) Revenue
451.40M384.70M
Rest of the World Revenue
57.80M75.10M

Revenue Breakdown

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Revenue
915.60M767.20M
Medtech Revenue (Post-Q2 2023 Reporting)
652.60M607.70M
Medtech Revenue (Pre-Q3 2023 Reporting)
1.57B1.37B
Specialty Pharma Revenue
423.00M431.80M

Revenue Breakdown 2

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Pharmaceuticals Revenue
413.20M420.50M
Assistive Technology Revenue
915.30M765.90M
Medical Devices Revenue
311.50M322.70M
Nutrition & Other Food Revenue
307.00M251.80M
Other Product Revenue
44.70M45.90M

Adjusted EBITDA

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Adjusted EBITDA
250.20M212.00M
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)
131.80M138.30M
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)
382.00M350.30M
Specialty Pharma Adjusted EBITDA
44.50M59.20M
Other and Eliminations from Adjusted EBITDA
-24.10M-21.70M

EBIT

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Operating Profit
186.20M164.10M
Medtech Operating Profit (Post-Q2 2023 Reporting)
89.30M98.70M
Medtech Operating Profit (Pre-Q3 2023 Reporting)
275.50M262.80M
Specialty Pharma Operating Profit
21.20M33.40M
Other and Eliminations from Operating Profit
-26.20M-23.90M
Updated Sep 30, 2025. Data Source: Fiscal.ai.